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The inwardly rectifying K+ channel KIR7.1 controls
uterine excitability throughout pregnancy
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Vatish1, Jie Zhang1, Jerod S Denton4, Michael J Taggart5, Catherine Kettleborough6, David Tickle6, Jeff
Jerman6, Paul Wright6, Timothy Dale7, Srinivasan Kanumilli7, Derek J Trezise7, Steve Thornton8, Pamela
Brown9, Roberto Catalano9, Nan Lin10, Sarah K England2 & Andrew M Blanks1,*
Abstract
Abnormal uterine activity in pregnancy causes a range of impor-
tant clinical disorders, including preterm birth, dysfunctional
labour and post-partum haemorrhage. Uterine contractile patterns
are controlled by the generation of complex electrical signals at
the myometrial smooth muscle plasma membrane. To identify
novel targets to treat conditions associated with uterine dysfunc-
tion, we undertook a genome-wide screen of potassium channels
that are enriched in myometrial smooth muscle. Computational
modelling identified Kir7.1 as potentially important in regulating
uterine excitability during pregnancy. We demonstrate Kir7.1
current hyper-polarizes uterine myocytes and promotes quies-
cence during gestation. Labour is associated with a decline, but
not loss, of Kir7.1 expression. Knockdown of Kir7.1 by lentiviral
expression of miRNA was sufficient to increase uterine contractile
force and duration significantly. Conversely, overexpression of
Kir7.1 inhibited uterine contractility. Finally, we demonstrate that
the Kir7.1 inhibitor VU590 as well as novel derivative compounds
induces profound, long-lasting contractions in mouse and human
myometrium; the activity of these inhibitors exceeds that of other
uterotonic drugs. We conclude Kir7.1 regulates the transition from
quiescence to contractions in the pregnant uterus and may be a
target for therapies to control uterine contractility.
Keywords pregnancy; parturition; potassium channels; uterus; myometrium
Subject Categories Pharmacology & Drug Discovery; Urogenital System
DOI 10.15252/emmm.201403944 | Received 6 February 2014 | Revised 13 June
2014 | Accepted 2 July 2014 | Published online 23 July 2014
EMBO Mol Med (2014) 6: 1161–1174
Introduction
At the end of pregnancy, the quiescent uterus must become highly
contractile to mediate parturition. While the mechanisms initiating
parturition in mammals are diverse (Smith, 2007), a final common
pathway of uterine transition to a contractile phenotype appears to
converge on the expression of a group of proteins, including the
oxytocin receptor, prostaglandin endoperoxidase synthase 2, ion
channels and connexin 43, that alter the uterine myometrial smooth
muscle (MSM) cell from a state of low intrinsic excitability and
refractory to stimulation, to a state that has high intrinsic excitabil-
ity and is susceptible to stimulation (Garfield et al, 1977; Fuchs
et al, 1982; Slater et al, 1995; Garfield & Maner, 2007). Control of
stimulation is itself subject to complex gene-environment interac-
tions, which act either independently of, or complimentary to, the
underlying physiological changes of the uterus (Cha et al, 2013).
Irrespective of the underlying stimulus, the regulation of the
duration and frequency of the myometrial contraction critically
depends on control of calcium entry through voltage-gated L- and
T-type calcium channels (Amedee et al, 1987; Blanks et al, 2007).
Calcium is not only an important second messenger in the genera-
tion of force via calcium-calmodulin-dependent myosin light chain
kinase, but also depolarizes the plasma membrane, allowing for
activation of other voltage-dependent ion channels (Word et al,
1994; Brainard et al, 2007). This voltage-mediated control of uterine
excitability is modulated in a gestation-dependent manner in all
mammalian species. In particular, mid-gestation is characterized by
a hyperpolarized membrane potential close to the reversal potential
for potassium Ek (Casteels & Kuriyama, 1965). As pregnancy
progresses towards term, the myometrium becomes increasingly
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depolarized, to approximately 45 mV at parturition (Casteels &
Kuriyama, 1965; Parkington et al, 1999). The mechanism underpin-
ning this crucial, evolutionarily conserved process remains
unknown.
A number of potassium channels have been demonstrated to
play a role in shaping the myometrial action potential and modulat-
ing myometrial contractility (Brainard et al, 2007). The putative
roles for the different channels are diverse and depend on the physi-
ological environment. These roles range from voltage-dependent
modulation of the action potential waveform (Knock et al, 1999), to
modulating responses to intracellular calcium release through BKca
and SK3 (Khan et al, 1993; Pierce et al, 2008), intracellular ATP
concentration through KATP (Khan et al, 1998) and uterine stretch
through tandem pore channels (Tichenor et al, 2005).
Within the potassium channel super-family, inwardly rectifying
potassium channels represents good candidates for the regulation of
resting membrane potential. Kir7.1 is a member of the inwardly
rectifying potassium channel sub-family and is only 38% identical
to its closest relative, Kir4.2 (Doring et al, 1998; Krapivinsky et al,
1998; Partiseti et al, 1998). Kir7.1 is expressed in visceral tissues
and some neurones within the CNS (Krapivinsky et al, 1998;
Nakamura et al, 1999; Ookata et al, 2000; Shimura et al, 2001),
although little is known about its functional role. Studies in retinal
pigment epithelial cells indicate that the channel may play an inte-
gral role in setting resting membrane potential and modulating K+
recycling (Shimura et al, 2001). A rare genetic mutation in Kir7.1
causes autosomal-dominant snowflake vitreoretinal degeneration
characterized by congenital degeneration of ocular tissues including
the vitreous (Hejtmancik et al, 2008). Kir7.1 has also been linked to
developmental pathways. For example, the jaguar/obelix mutation
in zebra fish renders the Kir7.1 homologue non-functional. As a
result, melanophores fail to respond appropriately to external cues,
leading to melanosome aggregation and the phenotype of a broader
striping pattern (Iwashita et al, 2006). Kir7.1 may also be involved
in palate formation in mice. Kcnj13 was identified as one of 8 genes
whose mis-expression correlates with formation of cleft palate in
TGF3beta knockouts, though the precise role of the channel remains
to be described (Ozturk et al, 2013).
In this study, we demonstrate the crucial importance of Kir7.1
in modulating uterine contractility in mice and humans. We show
that the physiological function of Kir7.1 is to maintain a hyperpo-
larized membrane potential during uterine quiescence and that
removal of this hyperpolarizing drive renders the uterus more
excitable. Furthermore, we show that Kir7.1 also modulates the
action potential waveform, modifying the excitation-contraction
cycle by participating in key stages of repolarization. Pharmaco-
logical manipulation of this normal physiological process could be
an alternative strategy to treat an atonic uterus and obstetric
haemorrhage.
Results
The aim of our study was to identify a potassium channel with the
appropriate biophysical attributes to regulate the myometrial resting
membrane potential during gestation. To identify candidates, we
undertook a genome-wide qRT-PCR screen of all known K+
channels and associated subunits in cDNA pools generated from
laser-capture micro-dissected MSM and whole myometrial tissue. Of
seven transcripts enriched in MSM (Supplementary Table S1), only
KCNJ13 coded for a K+ channel (Kir7.1) with appropriate biophysi-
cal attributes. Kcnj13 transcript levels increased markedly in the
pregnant mouse uterus during mid-gestation, peaking on gestational
day (GD) 15, and followed by a sharp decline towards term (C57BL/
6J mice deliver in the morning of GD19; Fig 1A). KCNJ13 transcript
levels (Fig 1B) were also significantly lower (P < 0.05) in samples
taken from pregnant women in labour at term than in samples from
women not in labour. Immunoblot of myometrial lysates from both
labour and non-labour samples demonstrated a single immuno-
reactive band at ~42 kDa. As positive and negative controls, we also
tested human eye and adipose cell lysate, respectively (Fig 1C and
Supplementary Fig S1). Furthermore, Kir7.1 immuno-reactivity was
expressed in MSMs and was absent in the vasculature in both
human and mouse myometrial samples (Fig 1D), supporting the
specificity of the laser-capture screen.
To determine the functional significance of this K+ channel in
the uterus, we first investigated its electrophysiological properties in
freshly dissociated mouse MSMs. Under voltage-clamp conditions,
an inwardly rectifying potassium current (Fig 2A,B) was inhibited
by VU590, a known Kir7.1 inhibitor (Lewis et al, 2009). Consistent
with the finding that Kir7.1 expression was higher at GD15 than
GD18, the VU590 sensitive current density at -150 mV was signifi-
cantly greater (P < 0.05) on GD15 when compared to GD18
(Fig 2C).
To understand the function of Kir7.1 in the generation of the
myometrial action potential, we modelled the potential impact of
changes in Kir7.1 channel density on myometrial electrogenesis
using a Hodgkin-Huxley type current summing model. In free-
running simulations of membrane potential, increasing Kir7.1 chan-
nel density (within the range measured in our experimental data)
hyperpolarized resting membrane potential and decreased calcium
entry during the action potential (Fig 3). Furthermore, simulations
predicted that overall membrane conductance during the excited
phase of the action potential is so finely balanced that small changes
in Kir7.1 current density exerted large effects on membrane poten-
tial. Given its expression profile and biophysical properties, we
hypothesized that Kir7.1 is a key regulator of myometrial membrane
potential during gestation.
To assess the role of Kir7.1 in regulating uterine contractility
experimentally, we used lentiviral vectors expressing miRNA target-
ing Kcnj13 or the human Kir7.1 channel to inhibit and over-express
the channel in murine MSM, both in vitro and in vivo. Knockdown
of Kir7.1, in vitro, significantly increased the contractile activity inte-
gral (2.5-fold) (area under the time-force curve), duration (2.2-fold)
and maximum force (1.3-fold) of phasic contractions when
compared to scrambled miRNA control (Fig 4 and Supplementary
Fig S2). Conversely, over-expression of Kir7.1 significantly
decreased all three parameters. To determine whether these altera-
tions in contractility were due to electrogenic effects, we used sharp
microelectrodes to measure membrane potentials in the treated
myometrial strips. Knockdown of Kir7.1 depolarized resting
membrane potential with extended excited periods (Fig 5A,B),
whereas over-expression of Kir7.1 hyperpolarized resting membrane
potential and suppressed excitability (Fig 5C). Mean resting
membrane potentials differed significantly between the two
treatment groups (Fig 5D).
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Figure 1. Kir7.1 is expressed in uterine myocytes and is regulated in pregnancy in mice and humans.
A mRNA expression of Kcnj13 in mice (n = 5; mean  SD, per GD) normalized to GD13. *P < 0.05, Student’s t-test.
B mRNA expression of KCNJ13 (plotted as arbitrary units relative to 18s rRNA) in human myometrial samples from women at term not in labour (NIL) and at term in
labour (LAB) (n = 8; mean  SD, per group). *P < 0.05, Student’s t-test.
C Immunoblot of pooled lysates from eye, adipose tissue, NIL and LAB myometrium (n = 4) probed with antibody to human Kir7.1 (full blot available in Supplementary
Fig S1).
D Immunohistochemistry for Kir7.1 in human NIL myometrium (left panel), GD13 murine myometrium (centre panel) and GD15 murine myometrium (right panel).
Arrow indicates absence of staining in blood vessel. Inset panels show tissue treated with pre-absorbed primary antibody control counterstained with haematoxylin.
Scale bar = 100 lm.
A B C
Figure 2. Kir7.1 current in uterine myocytes decreases from mid-pregnancy to term.
A Measurement of inwardly rectifying, VU590-sensitive current in freshly dissociated GD15 murine myometrial cells. Shown are voltage-clamp recordings in the
presence and absence of 10 lM VU590.
B Current-voltage relation (n = 5; mean  SD, per data point) of current density [VU590 subtracted from control (vehicle alone)].
C Current density (pA/pF) at 150 mV and 500 ms in freshly dissociated murine myometrial cells from GD15 and GD18 (n = 5 mean  SD, per GD). *P < 0.05, Student’s
t-test.
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Ion channel function in vivo may differ to that observed
in vitro, because of either effects of the sample preparation, or
influence of in vivo factors not captured in vitro. To account for
these potential experimental confounders and to assess the pheno-
type of targeting Kir7.1 during pregnancy, we injected mice uteri
on GD9 with anti-Kir7.1 miRNA or scrambled miRNA control. To
record uterine activity, we surgically implanted a pressure
catheter with remote telemeter into the injected horn of both
knockdown and control mice. Intra-uterine pressure was recorded
continuously, and the animals were monitored by video. Mice in
which Kir7.1 was knocked down had significantly increased intra-
uterine pressure when compared to control mice (Fig 6 and
Supplementary Fig S3). Consistent with our findings that Kir7.1
expression and channel activity were higher at GD15 than GD18,
the effect on intrauterine pressure was more pronounced in mid-
gestation.
Figure 3. A free-running simulation of the effect on the myometrial action potential waveform of increasing densities of Kir7.1.
Time-dependent effect of increasing Kir7.1 channel densities on Vm (mV, left) and [Ca]i (nM, right). Increasing density of Kir7.1 within experimentally determined values
hyperpolarizes resting membrane potential, whereas decreasing membrane excitability during depolarizing excursions in Vm leading to decreased calcium entry.
A B C
D E F
Figure 4. Knockdown of Kir7.1 in vitro increases myometrial activity and promotes tonic contractions.
A–C Representative time-force recordings of phasic contractions demonstrating (A) the effect of scrambled miRNA compared to (B) knockdown (Anti-Kir7.1) and (C)
overexpression (+Kir7.1) of Kir7.1 on contractility in murine GD15 myometrial strips.
D–F Mean data are summarized (n = 8; mean  SD, per group of experiments) as activity integral (area under the time-force curve) (D), contraction duration (E) and
maximum force (F). *P < 0.05, compared to scrambled control by ANOVA with Tukey’s post hoc test.
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The increased contractility associated with Kir7.1 knockdown
raised the possibility that pharmacological targeting of this ion
channel could be of clinical value, for example in the management
of severe post-partum haemorrhage. To assess this possibility,
we first performed current clamp microelectrode recordings of
spontaneous action potentials in isolated murine myometrial strips.
We observed slow, inter-contraction, depolarization of resting
membrane potential followed by transient complex action poten-
tials (Fig 7). Administration of 10 lM VU590 rapidly depolarized
resting membrane potential to threshold (Fig 7Ai), followed by a
sustained plateau potential that was reversible on wash out
(Fig 7Aii and Aiii). In myometrial strips from women, application
of VU590 increased the activity integral, largely due to an increase
in contraction duration (Fig 7B), with contractions lasting several
hours observed.
To assess the potential therapeutic benefit of inhibiting Kir7.1,
we compared the effect of VU590 with oxytocin, the established
front-line treatment for post-partum haemorrhage. The effect of
VU590 on contractile force in samples taken from GD15 and
GD18 mice was dependent on dose and gestation (Fig 8A) and
when used in combination with oxytocin, increased activity inte-
gral by 172  14 fold and 90  42 fold on GD15 and GD18,
respectively, as compared to 4  2 fold and 8  3 fold for OXT
treatment alone (Fig 8B). The effect of VU590 was similar in
human term myometrium, which was also dose-dependent, with
the observed increase in activity integral, largely due to an
increase in contraction duration (Fig 8C,D). Importantly, sufficient
channels remain at term to generate a significant phenotypic
effect, underscoring the potential post-partum benefit of pharma-
cological intervention.
A B
C D
Figure 5. Knockdown of Kir7.1 in vitro depolarizes resting membrane potential.
A–C Representative membrane potential recordings in current clamp configuration from murine myometrial strips (A) treated with scrambled control miRNA (B) treated
with Kir7.1 knockdown (Anti-Kir7.1) and (C) overexpressing Kir7.1 (+Kir7.1).
D Resting membrane potential in current clamp configuration from murine myometrial strips (n = 6; mean  SD) from experiments depicted in (5A–C). *P < 0.05 by
Student’s t-test.
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To expand the pharmacological tools for Kir7.1 inhibition, we
used population patch-clamp technology to screen a library of
known ion channel inhibitors in a Chinese Hamster Ovary cell line
expressing Kir7.1 (Supplementary Fig S4 and Supplementary Meth-
ods). We identified compounds with different structures than
VU590 to assess whether the phenotype of Kir7.1 inhibition was
similar (Fig 9A). We also manufactured a control compound 1,3-Bis
(5-nitro-1H-benzo[d]imidazol-2-yl)propane (BNBI), which is known
to inhibit the structurally related Kir1.1 (Renal outer medulla potas-
sium channel) but does not inhibit Kir7.1 (Bhave et al, 2011).
Administration of 100 lM BNBI had no detectable effect on uterine
contractility in the GD15 mouse (Fig 9B), suggesting that loss of effi-
cacy for Kir7.1 inhibition is associated with loss of pro-contractile
activity. Finally, administration of 10 lM MRT2000769, a potent
Kir7.1 inhibitor that is structurally unrelated to VU590, induced
long-lasting contractions similar to those observed with VU590
(Fig 9C). The effectiveness of MRT2000769 further supported the
correlation between effective Kir7.1 inhibition and the phenotype of
long-lasting contractions (Supplementary Fig S5).
Discussion
Inwardly rectifying potassium channels are known to regulate
diverse but important physiological processes such as insulin secre-
tion in the pancreas, regulation of the cardiac action potential, para-
sympathetic stimulation and potassium reuptake in the kidney
(Hibino et al, 2010). In most cases, the channels act to hyperpolar-
ize resting membrane potential by remaining persistently open,
allowing the efflux of potassium. In excitable tissues, this dampens
electrical activity, while in epithelial cells, the potassium gradient
created in combination with energy-dependent ion pumps is used to
transport other ions. In secretory cells, inhibition of the current
causes depolarization and calcium entry leading to a secretion event
(Liu et al, 2001; Ashcroft, 2005; Hebert et al, 2005). The important
physiological roles of Kir channels are underscored by the many
diseases that are associated with Kir channel malfunction, such as
Bartter’s syndrome, Anderson syndrome, short Q-T syndrome and
neonatal diabetes (Derst et al, 1997; Andelfinger et al, 2002; Edghill
et al, 2004; Priori et al, 2005; Ellard et al, 2007).
Here we present the novel finding that Kir7.1 is a crucial regula-
tor of membrane potential in uterine myocytes during pregnancy in
both mice and humans. In mid-gestation, high expression of Kir7.1
keeps the resting membrane potential close to the reversal potential
for potassium, increasing the depolarizing drive required to initiate
an action potential, calcium entry and subsequent contraction. At
term, this damping of excitability is lost by reduction, but not
complete loss, of Kir7.1. Our results also indicate that inhibition of
Kir7.1 when combined with oxytocin administration is synergistic, a
mechanism that may be related to the sensitivity of Kir7.1 to intra-
cellular phosphatidylinositol 4,5-bisphosphate depletion (Pattnaik &
Hughes, 2009). Such a mechanism, when acting in conjunction with
a decreased gap junction density and decreased receptors to stimula-
tory ligands, could provide a robust means of maintaining uterine
quiescence during gestation (Garfield et al, 1977; Fuchs et al, 1982;
Smith, 2007).
Within the Kir superfamily, Kir7.1 displays several unique prop-
erties such as low sensitivity to Ba2+ and Cs+, low single channel
conductance, no internal block by Mg2+ ions, and a relative insensi-
tivity to external K+ concentration, tetraethylammonium
(IC50 > 10 mM) or 4-aminopyridine (IC50 ~10 mM) (Krapivinsky
et al, 1998). In in vitro expression systems, Kir7.1 exhibits rapid
Figure 6. Knockdown of Kir7.1 in vivo significantly increases intrauterine pressure.
Mice in which Kir7.1 was knocked down (Anti-Kir7.1) had significantly increased intrauterine pressure when compared to mice injected with scrambled miRNA lentivirus
(scrambled) from GD13 to GD18 (Fig 6 and Supplementary Fig S3). (n = 6 per time point). *P < 0.05; see methods for statistical model.
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activation kinetics and is essentially non-inactivating at potentials
negative to 40 mV with a small single channel conductance in both
recombinant and native cells (Doring et al, 1998; Krapivinsky et al,
1998; Shimura et al, 2001). Since the channel has a low conduc-
tance and little voltage or time dependence in physiological ranges,
high expression of this channel gives rise to a stable and hyperpolar-
ized resting membrane potential. Thus, the biophysics of Kir7.1 is
ideally suited to regulating myometrial smooth muscle cells during
mid-gestation quiescence.
Transgenic mouse models have demonstrated the critical nature
of control of myometrial membrane potential during parturition. For
example, mice overexpressing the small conductance potassium
channel SK3 suffer acute uterine dystocia, and both mother and
pups die during delivery (Bond et al, 2000). Similarly, mice
harbouring a smooth muscle specific deletion of the important uter-
ine gap junction protein connexin43 demonstrate a significant delay
in delivery and increased mortality of pups (Doring et al, 2006).
These data, in conjunction with our in vivo observations demon-
strating a significant increase in intrauterine pressure in the absence
of endocrine changes, underline the importance of the development
of uterine excitability during gestation to the overall delivery
process. It is notable that the decrease in Kir7.1 expression precedes
progesterone withdrawal in the mouse suggesting that modulation
of excitability is, at least in part, independent of progesterone. These
biophysical factors act in addition to, and in concert with, other
endocrine/paracrine changes that alter uterine stimulants (Cha et al,
2013) and lead to uterine disorders such as preterm labour or
dysfunctional labour. The overall role of membrane potential in the
control of parturition in the context of other controlling factors is
summarized in Fig 10.
In addition to a clear effect on resting membrane potential, our
computer modelling predicted that increasing Kir7.1 activity
A
B
i
i
iii
i
i ii iii
ii
Figure 7. Pharmacological inhibition of Kir7.1 in vitro in human and murine myometrium induces membrane depolarization and long-lasting contractions.
A Representative membrane potential recording in current clamp configuration from a murine GD15 myometrial strip. (i) Addition of 10 lM VU590 depolarizes resting
membrane potential (note slope change from resting potentials of preceding phasic bursts) and leads to a sustained plateau potential. (ii) Upon washout, spike
potentials recover as plateau potential hyperpolarizes. (iii) On complete washout, phasic bursting resumes.
B Addition of 1 nM oxytocin and 10 lM VU590 to human myometrial strips stimulates long-lasting contractions. (i) Initial component of the response is phasic,
followed by establishment of a tonic contraction.
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modulates calcium entry during the plateau phase of the complex
action potential, resulting in a decrease in contractile force and inef-
ficient contractions. Decreasing Kir7.1 has the effect of stressing the
repolarizing drive such that increased contributions from other K+
channels are required to ensure action potential repolarization
(Supplementary Fig S6) (Fink et al, 2006; Greenwood et al, 2009;
McCallum et al, 2011). These effects explain the longer action
potentials observed during pharmacological inhibition and experi-
mentally induced reduction in the expression of Kir7.1 protein.
When Kir7.1 current density is reduced to very low levels, the
myometrial smooth muscle effectively loses phasic behaviour and
manifests a new tonic-like tone. The greatly increased contraction
length induced by Kir7.1 inhibition may be useful for reducing
blood loss in an atonic uterus. As a treatment for post-partum haem-
orrhage, Kir7.1 block would have the advantage of being more
potent than current first line treatments. The mechanism of action
also circumvents the agonist pathways (Fig 10) targeted by current
treatments that are prone to desensitization during failed labour
inductions.
Materials and Methods
Ethical approval
All procedures involving women were conducted within the guide-
lines of The Declaration of Helsinki and were subject to local ethical
approval (REC-05/Q2802/107). Prior to surgery, informed written
consent for sample collection was obtained.
All animal procedures complied with the guidelines for the
care and use of animals set forth by the National Institutes of
Health. The Animal Studies Committee at Washington University
in St. Louis approved all protocols (protocol number 20110138 to
Sarah K. England). Adult C57BL/6J (Jackson Laboratory) female
mice were mated at 8 weeks of age until 6 months of age. Mice
were mated for 2-h time periods, and the presence of a copula-
tory plug was marked 0 days postcoitum (dpc). Animals were
housed in Washington University School of Medicine vivarium in
the BJCIH building, which is an AAALAC (Association for Assess-
ment and Accreditation of Laboratory Animal Care International)
A B
C D
Figure 8. Pharmacological inhibition of Kir7.1 in vitro in human and murine myometrium stimulates longer-lasting contractions than oxytocin.
A Dose- and gestation-dependent effect of VU590 on murine myometrial contractility [n = 5, activity integral expressed as a fold-change of pre-treatment contractions
(mean  SD, per GD)]. *P < 0.05 GD18 vs GD15 per dose by ANOVA with Tukey’s post hoc test.
B As in (A) but comparing the effect of 1 nM oxytocin with 1 nM oxytocin + 10 lM VU590. *P < 0.05 OT vs OT = VU590 per GD by Student’s t-test.
C Dose-dependent effect of VU590 (Black Bars) and VU590 + 1 nM oxytocin (grey bars) on human myometrial contractility (n = 8; activity integral expressed as
fold-change over pre-treatment contractions, mean  SD). *P < 0.05 compared to control by ANOVA with Tukey’s post hoc test.
D Dose-dependent effect of VU590 on contraction duration in human myometrial strips taken at term (n = 8, mean  SD). *P < 0.05 compared to control by ANOVA
with Tukey’s post hoc test.
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approved animal care facility. For in vivo intrauterine pressure
measurements, eight pregnant mice were injected with scrambled
miRNA and eight pregnant mice were injected with Kir7.1
miRNA.
Subject criteria and selection
Subjects were recruited into two groups, spontaneous labour (LAB)
and elective caesarean section not in labour (NIL) between 38 and
40 weeks gestation. The LAB group was undergoing caesarean
section for reasons of undiagnosed breech. LAB was defined as
regular contractions (< 3 min apart), membrane rupture and cervi-
cal dilatation (> 2 cm) with no augmentation.
Sample collection
At caesarean section, samples were collected before syntocin admin-
istration by knife biopsy from the lower uterine segment incision.
Samples were washed briefly in saline and flash-frozen in liquid
nitrogen for mRNA, immunoblot or immunohistochemistry
analyses. Samples for cell isolation or contractility experiments were
placed in ice-cold modified Krebs–Henseleit (m-KHS) solution and
used the same day.
Laser capture screen
mRNA was extracted from 100 mg of frozen human myometrium
using Trizol reagent (Invitrogen), and further column purified by
RNeasy kit (Qiagen) according to the manufacturer’s instructions.
Total RNA was quantified by spectrophotometer and further tested
for quality and purity by bioanalyser (Agilent Technologies) accord-
ing to the manufacturer’s instructions. cDNA was generated from
100 ng of mRNA using Superscript III (Invitrogen) according to the
manufacturer’s instructions and stored at 80°C until qRT-PCR
analysis.
Laser Capture Microdissection (LCM): All slides, LCM caps,
Haematoxylin and Eosin (H&E) Staining Kit for LCM and solutions
were obtained from Molecular Machines & Industries. Briefly,
cryomold-mounted myometrial samples were transferred from
70°C and equilibrated in a pre-cooled cryostat (30°C) for
10 min. Sections (8 lM) were cut and H&E stained according to
A
B C
Figure 9. Stimulation of uterine contractions correlates with Kir7.1 inhibitory potency.
A The structures of the three compounds tested in this study. BNBI, a potent Kir1.1 inhibitor does not inhibit Kir7.1. MRT2000769 is structurally unrelated to VU590
and was identified as inhibiting Kir7.1 in a high throughput electrophysiology screen. VU590 is the first described inhibitor of Kir7.1.
B, C Effects of BNBI (B) and MRT2000769 (C) on murine GD15 myometrial contractility.
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the manufacturer’s instructions. Slides were dehydrated in graded
alcohols and xylene and placed in a desiccator until laser capture.
At least 50,000 lm2 of human uterine myocytes was captured for
each gene. mRNA was extracted from each isolation by using the
Picopure RNA isolation kit (Arcturus) according to the manufac-
turer’s instructions. Reverse transcription was as previously
described. PCR primer design and qRT-PCR are described in the
Supplementary Methods.
Immunohistochemistry
Frozen sections (8 lM) were fixed in ice-cold acetone for 5 min
prior to incubation in phosphate-buffered saline (PBS). Endogenous
peroxidase activity was blocked by immersing the slides for 30 min
in freshly prepared 0.3% hydrogen peroxide in PBS. Slides were
pre-incubated in 1.5% non-immune goat serum in PBS for 30 min at
room temperature and then in primary anti-Kir7.1 antibody (1:100;
Alomone) overnight at 4°C in a humidified chamber. Primary
Figure 10. Model of the role of Kir7.1 in maintenance of uterine quiescence.
In normal labour in the human myometrium, changes take place over a number of weeks that increase both the intrinsic electrical excitability of the cell (blue box) and, by
altering cellular receptors and contractile machinery, the susceptibility to stimulation. Alterations in stimulation either by infection or gene-environment interaction can
precipitate preterm labour (Cha et al, 2013); however, changes in control of the myometrial membrane potential or interference with functional gap junctions can affect
labour even under normal endocrine conditions (Bond et al, 2000; Doring et al, 2006). In this study, we demonstrate that alteration of the function of a single potassium
channel profoundly alters uterine contractility. Loss of Kir7.1 function depolarizes the plasmamembrane and promotes voltage-gated calcium entry. In addition, the duration
of the depolarization is extended, preventing the normal phasic contractions. In this way, the process of excitation-contraction coupling in uterine myocytes overrides
pharmaco-contraction coupling. This effect could be used for therapeutic benefit. (Key: CPI-17 = C-kinase potentiated protein phosphatase-1 inhibitor. CX26 = Connexin 26.
CX43 = Connexin 43. CX45 = Connexin 45. GEFs = Guanine nucleotide exchange factors. GPCR = G-protein coupled receptors. IP3 = inositol 1,4,5-trisphosphate.
IP3R = inositol 1,4,5-trisphosphate receptor. MLC = Myosin light chain. MLCp = Phosphorylated myosin light chain. PIP2 = Phosphatidylinositol 4,5-bisphosphate. PLC
b = Phospholipase C. RHOgtp = Ras homologue gene family, member A. RHO-K = Rho-associated, coiled-coil containing protein kinase 1.)
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antibody pre-absorbed for 24 h with recombinant antigen served as
negative control. Staining was visualized using the Vectastain Elite
ABC rabbit IgG kit (Vector Laboratories) according to the manufac-
turer’s instructions.
Immunoblot
After tissue was suspended in RIPA lysis buffer containing protease
inhibitor cocktail tablets, mechanically homogenized and cleared by
centrifugation, the supernatant was aliquoted and frozen. Whole
tissue and protein lysates from adult human eye, adult mouse
adipose and adult mouse brain were purchased from Novus Biologi-
cals (Cambridge, UK) at a stock concentration of 5 mg/ml. All
protein concentrations were confirmed with the BioRad assay (Bio-
Rad laboratories, Hemel Hempstead, UK). A total of 40 lg of
protein per sample (pooled from 4 biopsies each for NIL and LAB
samples) was subjected to SDS-PAGE according to standard proto-
cols. The membrane was blocked in 5% milk protein solution
(Marvel, Lincs, UK) for 1 h at room temperature, incubated with
primary rabbit polyclonal anti Kir7.1 antibody (1:200; Alomone
Labs, Jerusalem) overnight at 4°C in blocking buffer and then incu-
bated with polyclonal goat anti-rabbit HRP secondary antibody
(1:100; Dako, Ely, UK). ECL Plus (GE Healthcare LTD, Amersham
place, UK) was used to detect signal. To confirm equal loading, the
blot was treated with Restore western blot stripping buffer (Thermo
Fisher Scientific, Hemel Hempstead, UK) for 15 min at room
temperature, washed, blocked and re-probed with an antibody to
human b-actin.
Electrophysiology
Cell isolation
Strips of myometrium from the longitudinal layer (2 × 2 × 20 mm)
of time-mated C57BL/6J mice were isolated and washed in Ca2+
and Mg2+ free Hank’s balanced salt solution (HBSS) at 37°C for 10,
20 and 30 min, respectively, followed by 45 min incubations in
digestion solution (Roche Blendzyme 3) at 37°C according to the
manufacturer’s instructions. Digestion was terminated by several
dilutions with fresh HBSS. Cells were dispersed by slow trituration
through a wide-bore fire-polished glass pipette in HBSS. Single
myometrial cells were filtered through a 200-lM gauze and stored
in HBSS for use within six hours.
Voltage clamp
A drop of myometrial cell suspension was placed in a glass-
bottomed Petri dish and mounted on the stage of an inverted
microscope (IX51, Olympus). After settling (~ 10 min), cells were
perfused with bath solution at a rate of 1–2 ml/min at 37°C. Patch
pipettes were fabricated (Model P-87; Sutter Instruments, Novato,
CA, USA) from 1.5-mm glass capillaries and had a resistance of
2.0–4.0 MΩ when filled with pipette solution (containing in mM:
KCL 140; EGTA 1.1; CaCl2 0.06; Hepes 10; MgCl2 2; adjusted to
pH 7.2 at 25°C with 5 M NaOH). Liquid junction potential was
zeroed prior to seal formation. Transmembrane currents were
recorded with an amplifier (Axopatch 700b; Axon Instruments)
using the perforated patch configuration of the whole cell patch-
clamp technique (Rae et al, 1991). The antibiotic amphotericin B
(720 lg/ml) was used to perforate the cell membrane. Series resis-
tance was compensated after membrane perforation. Currents were
elicited by stepping to a range of potentials between 150 mV and
+80mV from a holding potential of 60 mV. To isolate currents
that were sensitive to inhibition by drug application, difference
currents were obtained by electronic subtraction of traces.
Currents were filtered at 10 kHz and sampled at 5 kHz. Voltage
protocols were delivered via a Digidata 1440a computer interface
using pCLAMP 9.0 software (Molecular Devices, Sunnyvale, CA,
USA).
Current clamp
Strips (5 × 10 mm) of murine myometrium from the longitudinal
layer were pinned out on a sylgard base and perfused with m-KHS
containing (in mM: NaCl, 133; KCl, 4.7; Tes, 10; glucose, 11.1;
MgSO4, 1.2; KH2PO4, 1.2; CaCl2, 2.5; adjusted to pH 7.4 at 25°C
with NaOH) at 37°C on an upright microscope (MVX10, Olympus).
Tissue was incubated with 5 lM wortmannin (Sigma) to prevent
spontaneous contractions from dislodging impalements. Smooth
muscle cells were impaled with glass microelectrodes filled with
2 M KCl of resistance 80–120 MΩ. Transmembrane potentials were
recorded with an amplifier (Axopatch 700b; Axon Instruments)
and a Digidata 1440a computer interface running pCLAMP 9.0
software.
In vitro knockdown and contractility
Strips of GD15 or GD18 myometrium from the longitudinal layer
(2 × 2 × 20 mm) were washed in sterile Ca2+ and Mg2+ free HBSS
DMEM/F-12. Strips were placed (in triplicate) under 1.5× slack
length tension in media containing 2% dextran-coated charcoal-
treated foetal bovine serum with 0.5 mM 8-bromo-cAMP (Sigma),
106 M medroxyprogesterone acetate (Sigma) and pLenti6-cppt-
CMV-mCherry-mouse 543A miRNA (Anti-Kir7.1), pLenti6-cppt-
CMV-mCherry-neg miRNA (Scrambled), or pLenti6-cppt-CMV/TO-
humKir7.1-IRES-mCherry-opre (+Kir7.1). Construction of lentiviral
vectors is detailed in the Supplementary Methods.
On day five, strips were placed under 2mN tension in a four
channel flatbed organ bath (DMT) in m-KHS solution. Isometric
force was recorded on ADI Instruments LABCHART software. Activ-
ity integral was measured as the area under the time-force curve
(mN/s) over a 20-min period. Contraction duration was determined
as the mean duration (rise and fall to baseline) of contractions
within a 20-min period. Maximum force was determined as the peak
force measurement within a 20-min period. All measurements were
made over the same time period for all strips.
In vivo intrauterine pressure measurements
C57BL/6J time-mated mice were anesthetized on GD8 to GD10 by
intraperitoneal injection of ketamine (100 mg/kg) plus xylazine
(10 mg/kg, IP), and a PhysioTel PA-C10 transmitter (Data Sciences
International) was implanted in one horn of the pregnant uterus
between the uterine wall and foetal sacs. At this time, 3.7 × 105
particles/ml of pLenti6-cppt-CMV-mCherry-Neg miRNA (scrambled)
or pLenti6-cppt-CMV-mCherry-miRNA mouse Kir7.1 (Anti-Kir7.1)
were injected into the uterine muscle of the implanted horn. Five
days later, uterine pressures were continuously measured every
10 s at 500 Hz with Dataquest A.R.T. data acquisition system
version 4.31 (DSI) for 4–8 days.
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Data analysis and statistics for telemetry studies
Longitudinal changes in intrauterine pressure after infection with
pLenti6-cppt-CMV-mCherry-Neg miRNA (scrambled) or pLenti6-
cppt-CMV-mCherry-miRNA mouse Kir7.1 (Anti-Kir7.1) were analy-
sed by using a linear-mixed effect (LME) model implemented by
PROC MIXED in SAS 9.3. Before analysis, data were first temporally
aligned according to gestational days. The dependent (response)
variable was taken as the hourly average intrauterine pressure.
Fixed effects were treatment group (scrambled vs miRNA), gestation
day and their interaction. Random intercepts were also used to
incorporate mouse-specific effects. In addition, a first-order autore-
gressive correlation structure was used to account for the repeated
measurements over time, which implies that the temporal correla-
tion among repeated measures decays as a power function of the
time lag. Residuals from initial LME analysis displayed a skewed
distribution, and a square-root transformation of the response vari-
able was found to be effective to correct the non-normality in the
residuals. A few mice had negative hourly average pressures in
certain hours, and 58 such observations (around 3% of the entire
data set and split equally between the scrambled and miRNA group)
were excluded from the analysis.
Compound screening
Cell line generation, cell culture, and Kir7.1 automated electrophysi-
ology assay and data analysis are all described in the Supplementary
Methods. The MRCT ion channel focused compound file was
selected in collaboration with the Dundee Hit Finding Unit and
consisting of ~ 4,000 compounds. The set covered 119 bioactive
templates from nine categories of ion channel targets and molecular
weights of the screening compounds ranged between 150 and 450.
Computational simulations
Computational simulations are described in detail the Supplemen-
tary data.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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